← All trials
NCT02277132
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2015
- Primary completion
- Jan 1, 2018
- Completion date
- Jan 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 354
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of AmsterdamLead sponsor
- University of AmsterdamStudy chair
- University of British ColumbiaStudy chair
- Leiden UniversityStudy chair
- Perinataal Centrum MMC VeldhovenStudy chair
- ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator
- Free University of AmsterdamStudy chair
- University of AmsterdamOverall official - principal investigator
- University of AmsterdamReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.